title: The role of point of care testing for patients with acute pharyngitis.
abstract: BACKGROUND
  There is no consensus favoring a particular strategy for evaluating patients with pharyngitis.
  
  
  OBJECTIVE
  To compare a clinical decision aid and a rapid office-based point of care (POC) test with routine culture for group A beta-hemolytic streptococcus (GAS).
  
  
  METHODS
  Prospective observational study.
  
  
  METHODS
  Among 179 patients enrolled, 150 were eligible and 148 had POC testing and cultures initially performed.
  
  
  METHODS
  An encounter form included eligibility criteria, clinical information based upon the Centor rule, and treatment provided. Sensitivity and specificity of POC test compared to routine culture for GAS.
  
  
  RESULTS
  Thirty-eight patients (25.7%) had a positive GAS culture. The POC test was 92.1% sensitive (95% confidence interval [CI] 80% to 98%) and 100% specific (95% CI 97% to 100%). Although the Centor rule did not adequately discriminate among symptomatic patients with or without GAS (receiver operating curve area 0.63), the 3 patients with a false-negative POC test had a Centor score of less than 2. Among patients with a negative POC test, 26% initially received antibiotics.
  
  
  CONCLUSIONS
  For patients with a Centor score of > or =2, a POC test was highly sensitive for GAS. Future studies should confirm these results and assess whether implementation of POC testing as part of a local practice guideline can decrease variability in testing and treatment.
authors.affiliation: General Medicine Division, Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. satlas@partners.org
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Atlas
authors.forename: Steven M
authors.initials: SM
authors.lastname: McDermott
authors.forename: Carol
authors.initials: C
authors.lastname: Mannone
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Barry
mesh_terms: D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010612:Pharyngitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D019095:Point-of-Care Systems; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy; D013297:Streptococcus pyogenes
chemical_list: D000900:Anti-Bacterial Agents